Rallybio downgraded to Neutral from Overweight at JPMorgan
PremiumThe FlyRallybio downgraded to Neutral from Overweight at JPMorgan
4M ago
Rallybio files to sell 3.64M shares of common stock for holders
Premium
The Fly
Rallybio files to sell 3.64M shares of common stock for holders
4M ago
Rallybio reports Q1 EPS (47c), consensus (47c)
Premium
The Fly
Rallybio reports Q1 EPS (47c), consensus (47c)
4M ago
Rallybio reports Q4 EPS (50c), consensus (46c)
PremiumThe FlyRallybio reports Q4 EPS (50c), consensus (46c)
6M ago
Rallybio price target lowered to $13 from $14 at Wedbush
Premium
The Fly
Rallybio price target lowered to $13 from $14 at Wedbush
7M ago
Rallybio price target lowered to $8 from $16 at JMP Securities
Premium
The Fly
Rallybio price target lowered to $8 from $16 at JMP Securities
7M ago
Rallybio to begin RLYB212 study in 2H, cash runway extended into Q3
PremiumThe FlyRallybio to begin RLYB212 study in 2H, cash runway extended into Q3
8M ago
Rallybio price target lowered to $15 from $18 at Evercore ISI
Premium
The Fly
Rallybio price target lowered to $15 from $18 at Evercore ISI
9M ago
Rallybio announces data for RLYB11, extends runway to Q325
Premium
The Fly
Rallybio announces data for RLYB11, extends runway to Q325
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100